The following is the procedure of the palmitation taken from two different sources:
1-Recombinant protein G (Pierce, Rockford, IL) was derivatized with N-hydroxysuccinimide ester of palmitic acid (Sigma, St. Louis, MO), as previously described [8] except the palmitation reaction was conducted at 4°C for 1.5 hr instead of at 37°C. The lipid-derivatized protein G was purified on a 10 ml Sephadex G-25 (Pharmacia, Piscataway, NJ) column as described previously [29].
[8]. Dennis JE, Cohen N, Goldberg VM, Caplan AI. Targeted delivery of progenitor cells for cartilage repair. J Orthop Res. 2004;22:735–41. [PubMed]
[29]. Huang A, Huang L, Kennel SJ. Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. J Biol Chem. 1980;255:8015–8. [PubMed]
Source: Biomaterials. Author manuscript; available in PMC 2010 Aug 1.
Published in final edited form as:
Biomaterials. 2009 Aug; 30(22): 3702–3710.
Published online 2009 Apr 17. doi: 10.1016/j.biomaterials.2009.03.038
PMCID: PMC2693266
NIHMSID: NIHMS106547
Targeting mesenchymal stem cells to activated endothelial cells
In Kap Ko,1 Thomas J. Kean,1 and James E. Dennis1,*
2-Palmitated protein G (PPG) was derivitized as described previously by reacting recombinant protein G (Pierce, Rockford, IL) and N-hydroxysuccinimide ester of palmitic acid (Sigma, St. Louis, MO) followed by purification using Sephadex G-25 (Pharmacia, Piscataway, NJ).